Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hardy

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 5, 2014
Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapyLiam Masterson, Maral Rouhani, Neil P Donnelly, et al.
Microbes and Infection|April 20, 2023
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replicationFabien Le Chevalier, Pierre Authié, Sébastien Chardenoux, et al.
Nature Communications|February 6, 2020
TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineagesDaria Bottai, Wafa Frigui, Fadel Sayes, et al.
The Journal of Clinical Investigation|August 28, 2012
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in micePierre Kyme, Nils H Thoennissen, Ching Wen Tseng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2022
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosaBenjamin Vesin, Jodie Lopez, Amandine Noirat, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Fluke-borne viruses are a risk factor for diseases caused by carcinogenic trematodesSujittra Chaiyadet, Tom Roblin, Anais Fauchois, et al.
Journal of Natural Products|February 9, 2019
LC-HRMS-Database Screening Metrics for Rapid Prioritization of Samples to Accelerate the Discovery of Structurally New Natural ProductsJioji N Tabudravu, Léonie Pellissier, Alan James Smith, et al.
Emerging Infectious Diseases|September 25, 2024
Circovirus Hepatitis in Immunocompromised Patient, SwitzerlandBaptiste Hamelin, Philippe Pérot, Ian Pichler, et al.
EMBO Molecular Medicine|October 14, 2021
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic miceMin-Wen Ku, Pierre Authié, Maryline Bourgine, et al.
Journal of Virology|February 14, 2020
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8<sup>+</sup> T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency ReversalTalia M Mota, Chase D McCann, Ali Danesh, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 5, 2014
Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapyLiam Masterson, Maral Rouhani, Neil P Donnelly, et al.
Microbes and Infection|April 20, 2023
Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replicationFabien Le Chevalier, Pierre Authié, Sébastien Chardenoux, et al.
Nature Communications|February 6, 2020
TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineagesDaria Bottai, Wafa Frigui, Fadel Sayes, et al.
The Journal of Clinical Investigation|August 28, 2012
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in micePierre Kyme, Nils H Thoennissen, Ching Wen Tseng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2022
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosaBenjamin Vesin, Jodie Lopez, Amandine Noirat, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Fluke-borne viruses are a risk factor for diseases caused by carcinogenic trematodesSujittra Chaiyadet, Tom Roblin, Anais Fauchois, et al.
Journal of Natural Products|February 9, 2019
LC-HRMS-Database Screening Metrics for Rapid Prioritization of Samples to Accelerate the Discovery of Structurally New Natural ProductsJioji N Tabudravu, Léonie Pellissier, Alan James Smith, et al.
Emerging Infectious Diseases|September 25, 2024
Circovirus Hepatitis in Immunocompromised Patient, SwitzerlandBaptiste Hamelin, Philippe Pérot, Ian Pichler, et al.
EMBO Molecular Medicine|October 14, 2021
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic miceMin-Wen Ku, Pierre Authié, Maryline Bourgine, et al.
Journal of Virology|February 14, 2020
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8<sup>+</sup> T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency ReversalTalia M Mota, Chase D McCann, Ali Danesh, et al.
Pageof 14